Skip to content

NUTRITION SCIENCES

Active
Public limited companyfounded 199827 yrs activeBooiebos 5, 9031 Gent, BelgiumKBO/BCE: BE 0464.648.806
Summary

NUTRITION SCIENCES has been active since 1998 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €977,744 and a net result of -€343,443. Equity is growing by ~4.1% per year across the filed fiscal years. Its solvency ranks better than 68% of 737 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability0▼-71
Solvency86▲+12
Growth59▼-25
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13,000 at 30 days acceptable
Liquidity ample (current ratio 2.51 against 2.26 in 2024; short-term debt: 38.2% and cash: 6% of total assets), and 39.1% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 71
Relative position
BE, all sectors
reference
Architectural and engineering activities; technical testing and analysis (NACE 71)
about 56% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 27 years 0 30 y
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
25 d early
2024
3 d early
2023
on the day
2022
57 d late
2021
16 d late
2020
11 d late
2019
3 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 8 days after the deadline; the sector median for financial year 2024 is 8 days before the deadline, and 33% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 1 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 23 November 1998, NUTRITION SCIENCES was incorporated.1 Revenue went from EUR 77,807 in 2018 to EUR 135,329 in 2025 and headcount from 25 to 13.1 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€135,329▼ 38.1%
2024 · €218,477
EBIT margin
-238.3%▼ 302.7pp
2024 · 64.4%
Net result
-€343,443
2024 · €36,247
Working capital
€926,231▼ 36.7%
2024 · €1.5m
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 71, Architectural and engineering activities; technical testing and analysis, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover€169,800▲ 28.0%€175,628▲ 3.4%€163,906▼ 6.7%€218,477▲ 33.3%€135,329▼ 38.1%
Operating result-€317,406€190,211€734,039▲ 286%€140,612▼ 80.8%-€322,506
Net result-€366,701below the sector's middle half€110,237within the sector's middle half€418,912above the sector's middle half▲ 280%€36,247within the sector's middle half▼ 91.3%-€343,443below the sector's middle half
EBIT margin-186.9%▼ 657.5pp108.3%▲ 295.2pp447.8%▲ 339.5pp64.4%▼ 383.5pp-238.3%▼ 302.7pp
Equity€755,791within the sector's middle half▼ 32.7%€866,028within the sector's middle half▲ 14.6%€1.3mabove the sector's middle half▲ 48.4%€1.3mabove the sector's middle half▲ 2.8%€977,744within the sector's middle half▼ 26.0%
Total assets€4.0mabove the sector's middle half▲ 73.4%€4.5mabove the sector's middle half▲ 10.6%€5.4mabove the sector's middle half▲ 21.5%€2.7mwithin the sector's middle half▼ 49.8%€1.6mwithin the sector's middle half▼ 40.9%
Debt€3.3m▲ 173%€3.6m▲ 9.7%€4.1m▲ 14.9%€1.4m▼ 66.2%€628,347▼ 54.9%
Working capital€622,663above the sector's middle half▼ 35.7%€778,983above the sector's middle half▲ 25.1%€1.2mabove the sector's middle half▲ 58.1%€1.5mabove the sector's middle half▲ 18.9%€926,231within the sector's middle half▼ 36.7%
Solvency18.8%below the sector's middle half▼ 29.6pp19.5%within the sector's middle half▲ 0.7pp23.8%within the sector's middle half▲ 4.3pp48.7%within the sector's middle half▲ 24.9pp60.9%within the sector's middle half▲ 12.2pp
Current ratio1.19within the sector's middle half▼ 0.631.22within the sector's middle half▲ 0.031.30within the sector's middle half▲ 0.082.26within the sector's middle half▲ 0.962.51within the sector's middle half▲ 0.25
Return on assets (ROA)-9.1%below the sector's middle half▼ 33.9pp2.5%within the sector's middle half▲ 11.6pp7.7%within the sector's middle half▲ 5.3pp1.3%within the sector's middle half▼ 6.4pp-21.4%below the sector's middle half▼ 22.7pp
Staff (FTE)27.7within the sector's middle half▼ 4.2%27.6within the sector's middle half▼ 0.4%28.4above the sector's middle half▲ 2.9%26.5within the sector's middle half▼ 6.7%13.1within the sector's middle half▼ 50.6%
above within below the middle half (P25 to P75) of NACE 71, Architectural and engineering activities; technical testing and analysis, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€500,000€0€500,000Operating result 2021: -€317,406-€317,406Net result 2021: -€366,701-€366,701Operating result 2022: €190,211€190,211Net result 2022: €110,237€110,237Operating result 2023: €734,039€734,039Net result 2023: €418,912€418,912Operating result 2024: €140,612€140,612Net result 2024: €36,247€36,247Operating result 2025: -€322,506-€322,506Net result 2025: -€343,443-€343,44320212022202320242025-€500,000€0€500,000Operating result 2023: €734,039€734,000Net result 2023: €418,912€419,000Operating result 2024: €140,612€141,000Net result 2024: €36,247€36,200Operating result 2025: -€322,506-€323,000Net result 2025: -€343,443-€343,000202320242025
The operating result turns negative in 2025: a loss of €322,506 after €140,612 in 2024, the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.6m
Fixed assets €66,178 ▼ 28.7%
Current assets €1.5m ▼ 41.3%
Equity and liabilities €1.6m
Equity €977,744 ▼ 26.0%
Debt €628,347 ▼ 54.9%
Debt's share of the balance-sheet total falls from 51.3% to 39.1%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
-€295,909▼
2024 · €181,192
Cash flow
-€316,846▼
2024 · €76,827
Debt to equity
0.64▼
2024 · 1.06
ROE
-35.1%▼
2024 · 2.7%
Interest coverage
-45.63▼
2024 · 4.26
Debt ≤ 1 year
€613,682▼
2024 · €1.2m
Income taxes
€30,000▼
2024 · €57,739
Staff costs
€1.4m▼
2024 · €2.7m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 928 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 90% are still going.

  • Small
  • 20 years or older
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
1.1% went bankrupt
8.8% stopped otherwise
90% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 928 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 61 lines
Balance sheet Code20242025
Assets
Total assets20/58€2.7m€1.6m▼
Fixed assets21/28€92,774€66,178▼
Intangible fixed assets21€5,064€3,800▼
Tangible fixed assets22/27€82,048€56,716▼
Land and buildings22€0€0=
Plant, machinery and equipment23€59,676€43,228▼
Furniture and vehicles24€22,372€13,488▼
Financial fixed assets28€5,662€5,662=
Affiliated companies280/1€5,662€5,662=
Participating interests280€5,662€5,662=
Current assets29/58€2.6m€1.5m▼
Amounts receivable within one year40/41€2.2m€1.4m▼
Trade receivables40€1.7m€1.2m▼
Other amounts receivable41€523,985€251,783▼
Cash at bank and in hand54/58€337,834€96,220▼
Deferred charges and accrued income490/1€46,859-
Equity and liabilities
Total equity and liabilities10/49€2.7m€1.6m▼
Equity10/15€1.3m€977,744▼
Contributions10/11€200,000€200,000=
Capital10€200,000€200,000=
Issued capital100€200,000€200,000=
Reserves13€20,000€20,000=
Non-distributable reserves130/1€20,000€20,000=
Legal reserve130€20,000€20,000=
Profit (loss) carried forward14€1.1m€757,744▼
Amounts payable17/49€1.4m€628,347▼
Amounts payable within one year42/48€1.2m€613,682▼
Trade debts44€701,858€364,615▼
Suppliers440/4€701,858€364,615▼
Taxes, remuneration and social security45€456,616€249,068▼
Taxes450/3€239,568€190,976▼
Remuneration and social security454/9€217,048€58,092▼
Accrued charges and deferred income492/3€235,921€14,665▼
Income statement Code20242025
Operating income70/76A€5.7m€2.8m▼
Turnover70€218,477€135,329▼
Other operating income74€5.5m€2.6m▼
Non-recurring operating income76A-€127,600
Operating charges60/66A€5.6m€3.2m▼
Services and other goods61€2.8m€1.7m▼
Remuneration, social security and pensions62€2.7m€1.4m▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€40,580€26,597▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€3,655€1,099▼
Other operating charges640/8€1,924€2,536▲
Operating profit (loss)9901€140,612-€322,506▼
Financial income75/76B€10,908€15,548▲
Recurring financial income75€10,908€15,548▲
Income from financial fixed assets750€301€7,618▲
Other financial income752/9€10,607€7,930▼
Non-recurring financial income76B-€0
Financial charges65/66B€57,535€6,486▼
Recurring financial charges65€57,535€6,486▼
Debt charges650€42,501-
Other financial charges652/9€15,034€6,486▼
Profit (loss) for the period before taxes9903€93,985-€313,443▼
Income taxes67/77€57,739€30,000▼
Taxes670/3€57,739€30,000▼
Profit (loss) for the period9904€36,247-€343,443▼
Profit (loss) for the period to be appropriated9905€36,247-€343,443▼
Appropriation of the result
Profit (loss) to be appropriated9906€1.1m€757,744▼
Profit (loss) brought forward from the previous period14P€1.1m€1.1m▲
Social balance
Average headcount (FTE)908726.513.1▼

The notes to these accounts (40 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Operating income70/76A€7.4m€8.1m€9.0m€5.7m€2.8m▼ 50.1%
Turnover70€169,800€175,628€163,906€218,477€135,329▼ 38.1%
Other operating income74€7.3m€7.9m€8.8m€5.5m€2.6m▼ 52.9%
Non-recurring operating income76A----€127,600-
Operating charges60/66A€7.7m€7.9m€8.3m€5.6m€3.2m▼ 43.0%
Services and other goods61€4.9m€5.1m€4.7m€2.8m€1.7m▼ 39.7%
Remuneration, social security and pensions62€2.7m€2.7m€3.5m€2.7m€1.4m▼ 46.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€49,954€49,219€47,457€40,580€26,597▼ 34.5%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€32,369€23,787-€9,316€3,655€1,099▼ 69.9%
Other operating charges640/8€1,188€1,281€12,522€1,924€2,536▲ 31.8%
Operating profit (loss)9901-€317,406€190,211€734,039€140,612-€322,506▼ 329%
Financial income75/76B-€1,076€7,382€10,908€15,548▲ 42.5%
Recurring financial income75€1,768€1,076€7,382€10,908€15,548▲ 42.5%
Income from financial fixed assets750---€301€7,618▲ 2,428%
Other financial income752/9€1,768€1,076€7,382€10,607€7,930▼ 25.2%
Non-recurring financial income76B€133---€0-
Financial charges65/66B€47,572€77,034€150,342€57,535€6,486▼ 88.7%
Recurring financial charges65€47,572€77,034€150,342€57,535€6,486▼ 88.7%
Debt charges650€6,113€68,933€125,113€42,501--
Other financial charges652/9€41,459€8,100€25,229€15,034€6,486▼ 56.9%
Profit (loss) for the period before taxes9903-€363,077€114,253€591,079€93,985-€313,443▼ 434%
Income taxes67/77€3,624€4,016€172,167€57,739€30,000▼ 48.0%
Taxes670/3€3,624€4,016€172,167€57,739€30,000▼ 48.0%
Profit (loss) for the period9904-€366,701€110,237€418,912€36,247-€343,443▼ 1,048%
Profit (loss) for the period to be appropriated9905-€366,701€110,237€418,912€36,247-€343,443▼ 1,048%
Line20212022202320242025Change
Assets
Total assets20/58€4.0m€4.5m€5.4m€2.7m€1.6m▼ 40.9%
Fixed assets21/28€149,278€115,887€92,151€92,774€66,178▼ 28.7%
Intangible fixed assets21---€5,064€3,800▼ 25.0%
Tangible fixed assets22/27€143,616€110,224€86,489€82,048€56,716▼ 30.9%
Land and buildings22€103€0€0€0€0=
Plant, machinery and equipment23€54,396€52,553€40,450€59,676€43,228▼ 27.6%
Furniture and vehicles24€89,116€57,671€46,039€22,372€13,488▼ 39.7%
Financial fixed assets28€5,662€5,662€5,662€5,662€5,662=
Affiliated companies280/1€5,662€5,662€5,662€5,662€5,662=
Participating interests280€5,662€5,662€5,662€5,662€5,662=
Current assets29/58€3.9m€4.3m€5.3m€2.6m€1.5m▼ 41.3%
Amounts receivable within one year40/41€3.5m€4.0m€4.6m€2.2m€1.4m▼ 35.5%
Trade receivables40€3.3m€4.0m€4.6m€1.7m€1.2m▼ 30.5%
Other amounts receivable41€219,978€72,277€0€523,985€251,783▼ 51.9%
Cash at bank and in hand54/58€280,539€269,277€678,081€337,834€96,220▼ 71.5%
Deferred charges and accrued income490/1€69,685€36,546€30,014€46,859--
Equity and liabilities
Total equity and liabilities10/49€4.0m€4.5m€5.4m€2.7m€1.6m▼ 40.9%
Equity10/15€755,791€866,028€1.3m€1.3m€977,744▼ 26.0%
Contributions10/11€200,000€200,000€200,000€200,000€200,000=
Capital10€200,000€200,000€200,000€200,000€200,000=
Issued capital100€200,000€200,000€200,000€200,000€200,000=
Reserves13€20,000€20,000€20,000€20,000€20,000=
Non-distributable reserves130/1€20,000€20,000€20,000€20,000€20,000=
Legal reserve130€20,000€20,000€20,000€20,000€20,000=
Profit (loss) carried forward14€535,791€646,028€1.1m€1.1m€757,744▼ 31.2%
Amounts payable17/49€3.3m€3.6m€4.1m€1.4m€628,347▼ 54.9%
Amounts payable within one year42/48€3.3m€3.6m€4.1m€1.2m€613,682▼ 47.0%
Financial debts43€994,220€1.9m€0---
Credit institutions430/8€994,220€1.9m€0---
Trade debts44€1.8m€1.2m€748,500€701,858€364,615▼ 48.1%
Suppliers440/4€1.8m€1.2m€748,500€701,858€364,615▼ 48.1%
Taxes, remuneration and social security45€433,152€403,192€1.4m€456,616€249,068▼ 45.5%
Taxes450/3€3,713€7,729€624,659€239,568€190,976▼ 20.3%
Remuneration and social security454/9€429,439€395,463€734,764€217,048€58,092▼ 73.2%
Other amounts payable47/48--€2.0m---
Accrued charges and deferred income492/3€16,150€28,842€38,550€235,921€14,665▼ 93.8%
Line20212022202320242025Change
Profit (loss) for the period9904-€366,701€110,237€418,912€36,247-€343,443▼ 1,048%
+ Depreciation and write-downs630€49,954€49,219€47,457€40,580€26,597▼ 34.5%
Operating cash flow (approximation)-€316,747€159,456€466,369€76,827-€316,846▼ 512%
Investment in fixed assets (approximation)--€15,828-€23,721-€41,204€0▲ 100%
Change in cash--€11,262€408,805-€340,247-€241,614▲ 29.0%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
06-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
28-07
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
31-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Equity above €1mEq €1.3m ▲48.4%
2 profitable years in a row build equity to €1.3m.
26-09
NBB filing Annual accounts filed
fiscal year 2022 · full schema · 57 days late
2022
31-12
Financial Back to profitnet €110,237
Net result €110,237 after one loss-making year.
16-08
NBB filing Annual accounts filed
fiscal year 2021 · full schema · 16 days late
2021
11-08
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 11 days late
2020
31-12
Financial Back to profitnet €575,370
Net result €575,370 after 2 loss-making years.
31-12
Financial Equity above €1mEq €1.1m ▲105%
Equity rises from €547,122 to €1.1m.
03-08
NBB filing Annual accounts filed
fiscal year 2019 · full schema · 3 days late
2019
31-07
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
28-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
27-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 14 acts read
About the unread acts

We know of 14 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
14 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 2 establishment units since 1998
seat establishment All 2 establishment units on the map
Ground area
5.0 ha
Building footprint
1.5 ha
Volume, LiDAR
18,223 m³
2 parcels, Flanders · tallest building 13.3 m, ±2 floors. Linked by address, not a title deed.
8 companies at this address See who is registered here
2 establishment units
Booiebos 5, 9031 Gent
NACE 7413101
since 19982.089.796.110
NUTRITION SCIENCES
Industriepark-Drongen 3, 9031 GentFinancial service activities, except insurance and pension funding
since 20212.318.454.804
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44017D0928/00R000 Flanders 3.2 ha 1 · 1.2 ha -
44017D0937/00D000 Flanders 1.8 ha 1 · 2,492 m² 13.3 m · 2 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 owner · 1 holding

Chain of control

  1. NUSCIENCE GROUP 100%
  2. Nuscience Belgium 100%
  3. NUTRITION SCIENCES

Highest known parent: NUSCIENCE GROUP. The sources do not say who stands above it.

Owners 1

Holdings 1

  • Agrifirm Do Brasil Nutricao Animal LTDABRsubsidiary
    Equity BRL 107.3mResult -BRL 13.5m
    98%

According to the 2025 annual accounts of NUTRITION SCIENCES and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Public money · subsidies and aid

Flemish government

2023 · 1 entry · 746 EUR awarded · 746 EUR paid
Year Entries awardedpaid
2023 1 746 EUR746 EUR
Schemes
1 entry · 746 EUR · 746 EUR paid · Departement Werk en Sociale Economie

European Union, budget

2021 to 2022 · 5 entries · 1,076,776 EUR in total
Year Entries awarded
2022 2 696,244 EUR
2021 3 380,532 EUR
Projects
STOP SPREAD BAD BUGS - STOP SPREAD BAD BUGS: NOVEL ANTIMICROBIAL APPROACHES TO COMBAT MULTIDRUG RESISTANCE IN BACTERIA
Horizon Europe · 01-09-2022 to 31-08-2026 · 393,931 EUR
CIRCALGAE - CIRCULAR VALORISATION OF INDUSTRIAL ALGAE WASTE STREAMS INTO HIGH-VALUE PRODUCTS TO FOSTER FUTURE SUSTAINABLE BLUE BIOREFINERIES IN EUROPE
Horizon Europe · 01-10-2022 to 30-09-2026 · 302,312 EUR
NEOGIANT - THE POWER OF GRAPE EXTRACTS: ANTIMICROBIAL AND ANTIOXIDANT PROPERTIES TO PREVENT THE USE OF ANTIBIOTICS IN FARMED ANIMALS
Horizon Europe · 01-10-2021 to 30-09-2025 · 251,785 EUR
VIVALDI - INNOVATIVE BIO-BASED CHAINS FOR CO2 VALORISATION AS ADDED-VALUE ORGANIC ACIDS
Horizon Europe · 01-06-2021 to 31-05-2025 · 128,747 EUR

European research

22 projects · 2,628,818 EUR EU contribution
Programmes
14 entries · 1,606,045 EUR
6 entries · 720,461 EUR
2 entries · 302,312 EUR
Projects
CIRCular valorisation of industrial ALGAE waste streams into high-value products to foster future sustainable blue biorefineries in Europe
Horizon Europe · participant · 01-10-2022 to 30-09-2026 · 302,312 EUR · CIRCALGAE
BIOtechnological processes based on microbial platforms for the CONversion of CO2 from ironsteel industry into commodities for chemicals and plastics
Horizon 2020 · participant · 01-01-2018 to 30-06-2022 · 253,125 EUR · BIOCONCO2
The power of grape extracts: antimicrobial and antioxidant properties to prevent the use of antibiotics in farmed animals
Horizon 2020 · participant · 01-10-2021 to 31-03-2026 · 251,781 EUR · NeoGiANT
Enabling the exploitation of Insects as a Sustainable Source of Protein for Animal Feed and Human Nutrition
Seventh Framework Programme · participant · 01-02-2013 to 30-04-2016 · 248,250 EUR · PROTEINSECT
Biorefineries for the valorisation of macroalgal residual biomass and legume processing by-products to obtain new protein value chains for high-value food and feed applications
Horizon 2020 · participant · 01-06-2020 to 28-02-2025 · 219,525 EUR · ALEHOOP
Show 17 more projects
Value chains for disruptive transformation of urban biowaste into biobased products in the city context
Horizon 2020 · participant · 01-09-2019 to 31-08-2023 · 203,438 EUR · WaysTUP!
SCALABLE TECHNOLOGIES FOR BIO-URBAN WASTE RECOVERY
Horizon 2020 · participant · 01-11-2018 to 31-10-2022 · 199,500 EUR · SCALIBUR
Sustainable Production of Functional and Safe Feed from Food Waste
Seventh Framework Programme · participant · 01-08-2012 to 31-01-2016 · 194,100 EUR · NOSHAN
MICROALGAE PROTEIN INGREDIENTS FOR THE FOOD AND FEED OF THE FUTURE
Horizon 2020 · participant · 01-10-2019 to 31-12-2023 · 175,000 EUR · ProFuture
innoVative bIo-based chains for CO2 VALorisation as aDded-value organIc acids
Horizon 2020 · participant · 01-06-2021 to 31-05-2025 · 128,750 EUR · VIVALDI
Enhancing collaboration in research for Livestock
Seventh Framework Programme · participant · 01-06-2011 to 31-05-2013 · 118,556 EUR · RTD2FARM
Bright Farm by Precision Livestock Farming
Seventh Framework Programme · participant · 01-11-2012 to 31-10-2016 · 71,580 EUR · EU-PLF
European Network for integrating novel technologies for food processing
Seventh Framework Programme · participant · 01-05-2009 to 31-12-2013 · 63,900 EUR · HIGHTECH EUROPE
Disseminating Innovative Solutions for Antibiotic Resistance Management
Horizon 2020 · participant · 01-01-2019 to 30-06-2022 · 61,837 EUR · DISARM
DiscardLess – Strategies for the gradual elimination of discards in European fisheries
Horizon 2020 · participant · 01-03-2015 to 28-02-2019 · 45,063 EUR · DiscardLess
Nanostructured carriers for improved cattle feed
Horizon 2020 · participant · 01-02-2018 to 30-04-2023 · 36,000 EUR · NanoFEED
SUStainable INsect CHAIN
Horizon 2020 · participant · 01-10-2019 to 30-09-2023 · 32,027 EUR · SUSINCHAIN
Safe Food for Europe – Coordination of research activities and Dissemination of research results of EC funded research on food safety
Seventh Framework Programme · participant · 01-05-2011 to 30-04-2014 · 24,075 EUR · FOODSEG
STOP SPREAD BAD BUGS: novel antimicrobial approaches to combat multidrug resistance in bacteria
Horizon Europe · participant · 01-09-2022 to 31-08-2027 · STOP SPREAD BAD BUGS
Direct and indirect biorefinery technologies for conversion of organic side-streams into multiple marketable products
Horizon 2020 · participant · 01-11-2016 to 31-10-2019 · InDIRECT
Integrated cascades of PROcesses for the extraction and valorisation of proteins and bioactive molecules from Legumes, Fungi and Coffee agro-industrial side streams
Horizon 2020 · participant · 01-09-2018 to 31-10-2022 · Prolific
Optimal utilization of seafood side-streams through the design of new holistic process lines
Horizon 2020 · participant · 01-05-2019 to 31-10-2023 · WASEABI

Recognitions · licences · registrations

Legal Entity Identifier

54930096MC7KUJPOHM05
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 2,148 companies in sector 71209 we hold annual accounts for 1,090. 581 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded23-11-1998
Fiscal year end31-12
Activities, NACEBEL 2025
71209Other technical testing and analysis
72109Other research and development on natural sciences
86910Medical imaging and medical laboratories
E-invoicing
Reachable via Peppol
Peppol ID 0208:0464648806
Also 9925:BE0464648806

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.